{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:00:26Z","timestamp":1786132826688,"version":"build-2736575974"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1681\/asn.2013070799","type":"journal-article","created":{"date-parts":[[2014,7,10]],"date-time":"2014-07-10T23:17:16Z","timestamp":1405034236000},"page":"173-182","source":"Crossref","is-referenced-by-count":32,"title":["A Pathogenetic Role for Endothelin-1 in Peritoneal Dialysis-Associated Fibrosis"],"prefix":"10.1681","volume":"26","author":[{"given":"Oscar","family":"Busnadiego","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Loureiro-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lagares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Dotor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"P\u00e9rez-Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda J.","family":"L\u00f3pez-Armada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Lamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"L\u00f3pez-Cabrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Rodr\u00edguez-Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20230208","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/ki.1994.163","article-title":"Peritoneal dialysis.","volume":"45","author":"Chaimovitz","year":"1994","journal-title":"Kidney Int"},{"key":"R2-20-20230208","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1523-1755.1999.00264.x","article-title":"The peritoneal membrane in chronic peritoneal dialysis.","volume":"55","author":"Krediet","year":"1999","journal-title":"Kidney Int"},{"key":"R3-20-20230208","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrneph.2013.100","article-title":"Peritoneal dialysis\u2014current status and future challenges.","volume":"9","author":"Davies","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"R4-20-20230208","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0272-6386(12)80814-6","article-title":"Functional longevity of the human peritoneum: How long is continuous peritoneal dialysis possible? Results of a prospective medium long-term study.","volume":"23","author":"Selgas","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"R5-20-20230208","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1177\/089686080002002S05","article-title":"Neoangiogenesis in the peritoneal membrane.","volume":"20","author":"Krediet","year":"2000","journal-title":"Perit Dial Int"},{"key":"R6-20-20230208","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1177\/089686089501507S04","article-title":"First-line defense mechanisms in the peritoneal cavity during peritoneal dialysis.","volume":"15","author":"Brulez","year":"1995","journal-title":"Perit Dial Int"},{"key":"R7-20-20230208","first-page":"S5","article-title":"Atlas of peritoneal histology.","volume":"20","author":"Di Paolo","year":"2000","journal-title":"Perit Dial Int"},{"key":"R8-20-20230208","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1681\/ASN.V132470","article-title":"Morphologic changes in the peritoneal membrane of patients with renal disease.","volume":"13","author":"Williams","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R9-20-20230208","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/089686089901900605","article-title":"Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis.","volume":"19","author":"Mateijsen","year":"1999","journal-title":"Perit Dial Int"},{"key":"R10-20-20230208","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1046\/j.1523-1755.2001.59780042.x","article-title":"Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties.","volume":"78","author":"Plum","year":"2001","journal-title":"Kidney Int Suppl"},{"key":"R11-20-20230208","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/ndt\/gfl054","article-title":"Quantitative assessment of the peritoneal vessel density and vasculopathy in CAPD patients.","volume":"21","author":"Sherif","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R12-20-20230208","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00428-003-0963-3","article-title":"Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis.","volume":"444","author":"Jim\u00e9nez-Heffernan","year":"2004","journal-title":"Virchows Arch"},{"key":"R13-20-20230208","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrneph.2012.144","article-title":"Protecting the peritoneal membrane: Factors beyond peritoneal dialysis solutions.","volume":"8","author":"Pletinck","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"R14-20-20230208","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1681\/ASN.2009070694","article-title":"The pathophysiology of the peritoneal membrane.","volume":"21","author":"Devuyst","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R15-20-20230208","doi-asserted-by":"crossref","first-page":"ii2","DOI":"10.1093\/ndt\/gfl183","article-title":"Epithelial-to-mesenchymal transition of the mesothelial cell\u2014its role in the response of the peritoneum to dialysis.","volume":"21","author":"Selgas","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R16-20-20230208","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa020809","article-title":"Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells.","volume":"348","author":"Y\u00e1\u00f1ez-M\u00f3","year":"2003","journal-title":"N Engl J Med"},{"key":"R17-20-20230208","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1681\/ASN.2006111292","article-title":"Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: Pathologic significance and potential therapeutic interventions.","volume":"18","author":"Aroeira","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R18-20-20230208","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1159\/000142529","article-title":"The role of the TGF\/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutions.","volume":"109","author":"Yao","year":"2008","journal-title":"Nephron, Exp Nephrol"},{"key":"R19-20-20230208","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1681\/ASN.2004060436","article-title":"Transient overexpression of TGF-beta1 induces epithelial mesenchymal transition in the rodent peritoneum.","volume":"16","author":"Margetts","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R20-20-20230208","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1681\/ASN.V12102029","article-title":"Gene transfer of transforming growth factor-beta1 to the rat peritoneum: Effects on membrane function.","volume":"12","author":"Margetts","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R21-20-20230208","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/089686080302300604","article-title":"Basic mechanisms and clinical implications of peritoneal fibrosis.","volume":"23","author":"Margetts","year":"2003","journal-title":"Perit Dial Int"},{"key":"R22-20-20230208","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ki.2009.436","article-title":"Smad3-dependent and -independent pathways are involved in peritoneal membrane injury.","volume":"77","author":"Patel","year":"2010","journal-title":"Kidney Int"},{"key":"R23-20-20230208","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1681\/ASN.2010111197","article-title":"Blocking TGF-\u03b21 protects the peritoneal membrane from dialysate-induced damage.","volume":"22","author":"Loureiro","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R24-20-20230208","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1681\/ASN.2007010121","article-title":"Smad7 transgene attenuates peritoneal fibrosis in uremic rats treated with peritoneal dialysis.","volume":"18","author":"Guo","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R25-20-20230208","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/sj.ki.5002533","article-title":"Smad7 gene transfer inhibits peritoneal fibrosis.","volume":"72","author":"Nie","year":"2007","journal-title":"Kidney Int"},{"key":"R26-20-20230208","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/ndt\/gfp618","article-title":"BMP-7 blocks mesenchymal conversion of mesothelial cells and prevents peritoneal damage induced by dialysis fluid exposure.","volume":"25","author":"Loureiro","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R27-20-20230208","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1681\/ASN.2008040424","article-title":"HGF and BMP-7 ameliorate high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesothelium.","volume":"20","author":"Yu","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R28-20-20230208","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/jcp.48.4.330","article-title":"Endothelin-1 in idiopathic pulmonary fibrosis.","volume":"48","author":"Uguccioni","year":"1995","journal-title":"J Clin Pathol"},{"key":"R30-20-20230208","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.phrs.2011.01.014","article-title":"Role of endothelin in the cardiovascular system.","volume":"63","author":"Rodr\u00edguez-Pascual","year":"2011","journal-title":"Pharmacol Res"},{"key":"R31-20-20230208","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1161\/01.RES.0000078491.79697.7F","article-title":"Functional cooperation between Smad proteins and activator protein-1 regulates transforming growth factor-beta-mediated induction of endothelin-1 expression.","volume":"92","author":"Rodr\u00edguez-Pascual","year":"2003","journal-title":"Circ Res"},{"key":"R32-20-20230208","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/art.27307","article-title":"Endothelin 1 contributes to the effect of transforming growth factor beta1 on wound repair and skin fibrosis.","volume":"62","author":"Lagares","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R33-20-20230208","doi-asserted-by":"crossref","first-page":"11649","DOI":"10.1158\/0008-5472.CAN-05-2123","article-title":"Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.","volume":"65","author":"Rosan\u00f2","year":"2005","journal-title":"Cancer Res"},{"key":"R34-20-20230208","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1165\/rcmb.2006-0353OC","article-title":"Endothelin-1 induces alveolar epithelial-mesenchymal transition through endothelin type A receptor-mediated production of TGF-beta1.","volume":"37","author":"Jain","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R35-20-20230208","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/CIRCULATIONAHA.110.938217","article-title":"Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition.","volume":"121","author":"Widyantoro","year":"2010","journal-title":"Circulation"},{"key":"R36-20-20230208","doi-asserted-by":"crossref","first-page":"30444","DOI":"10.1074\/jbc.M111.263657","article-title":"A novel role of endothelin-1 in linking Toll-like receptor 7-mediated inflammation to fibrosis in congenital heart block.","volume":"286","author":"Alvarez","year":"2011","journal-title":"J Biol Chem"},{"key":"R37-20-20230208","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1681\/ASN.V10122585","article-title":"Volume stress-induced peritoneal endothelin-1 release in continuous ambulatory peritoneal dialysis.","volume":"10","author":"Morgera","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R38-20-20230208","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1046\/j.1523-1755.2003.00320.x","article-title":"Combined ETA\/ETB receptor blockade of human peritoneal mesothelial cells inhibits collagen I RNA synthesis.","volume":"64","author":"Morgera","year":"2003","journal-title":"Kidney Int"},{"key":"R39-20-20230208","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1517\/14740338.2014.859674","article-title":"Efficacy, safety and clinical pharmacology of macitentan in comparison to other endothelin receptor antagonists in the treatment of pulmonary arterial hypertension.","volume":"13","author":"Dingemanse","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"R40-20-20230208","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/157489010793351944","article-title":"Review on bosentan, a dual endothelin receptor antagonist for the treatment of pulmonary arterial hypertension.","volume":"5","author":"Serasli","year":"2010","journal-title":"Recent Patents Cardiovasc Drug Discov"},{"key":"R41-20-20230208","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/089686080902900218","article-title":"Chronic exposure of mouse peritoneum to peritoneal dialysis fluid: Structural and functional alterations of the peritoneal membrane.","volume":"29","author":"Gonz\u00e1lez-Mateo","year":"2009","journal-title":"Perit Dial Int"},{"key":"R42-20-20230208","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1006\/abio.1994.1042","article-title":"An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct.","volume":"216","author":"Abe","year":"1994","journal-title":"Anal Biochem"},{"key":"R43-20-20230208","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/0006-291X(89)92270-5","article-title":"Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells.","volume":"159","author":"Kurihara","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"R44-20-20230208","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1128\/MCB.00625-06","article-title":"Constitutive ALK5-independent c-Jun N-terminal kinase activation contributes to endothelin-1 overexpression in pulmonary fibrosis: Evidence of an autocrine endothelin loop operating through the endothelin A and B receptors.","volume":"26","author":"Shi-Wen","year":"2006","journal-title":"Mol Cell Biol"},{"key":"R45-20-20230208","first-page":"115","article-title":"Signaling in fibrosis: Targeting the TGF beta, endothelin-1 and CCN2 axis in scleroderma.","volume":"1","author":"Leask","year":"2009","journal-title":"Front Biosci (Elite Ed"},{"key":"R46-20-20230208","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.biocel.2012.07.028","article-title":"Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor beta 1 expression in skeletal muscle cells.","volume":"44","author":"Morales","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"key":"R47-20-20230208","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0022-3565(25)22357-6","article-title":"Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.","volume":"270","author":"Clozel","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"R48-20-20230208","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/art.20676","article-title":"Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist.","volume":"50","author":"Korn","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R49-20-20230208","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension.","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"key":"R50-20-20230208","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s40265-013-0156-6","article-title":"Macitentan: First global approval.","volume":"74","author":"Patel","year":"2014","journal-title":"Drugs"},{"key":"R51-20-20230208","first-page":"455","article-title":"Macitentan slows down the dermal fibrotic process in systemic sclerosis: In vitro findings.","volume":"27","author":"Corallo","year":"2013","journal-title":"J Biol Regul Homeost Agents"},{"key":"R52-20-20230208","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1124\/jpet.108.142976","article-title":"Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonist.","volume":"327","author":"Iglarz","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"R53-20-20230208","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S1043-4666(03)00101-7","article-title":"A synthetic peptide from transforming growth factor beta type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury.","volume":"22","author":"Ezquerro","year":"2003","journal-title":"Cytokine"},{"key":"R54-20-20230208","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cyto.2007.06.004","article-title":"Identification of peptide inhibitors of transforming growth factor beta 1 using a phage-displayed peptide library.","volume":"39","author":"Dotor","year":"2007","journal-title":"Cytokine"},{"key":"R55-20-20230208","doi-asserted-by":"crossref","first-page":"e65434","DOI":"10.1371\/journal.pone.0065434","article-title":"Transforming growth factor-beta inhibition reduces progression of early choroidal neovascularization lesions in rats: P17 and P144 peptides.","volume":"8","author":"Zarranz-Ventura","year":"2013","journal-title":"PLoS ONE"},{"key":"R56-20-20230208","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1089\/ars.2012.4653","article-title":"A synthetic peptide from transforming growth factor-\u03b21 type III receptor inhibits NADPH oxidase and prevents oxidative stress in the kidney of spontaneously hypertensive rats.","volume":"19","author":"Baltan\u00e1s","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"R57-20-20230208","doi-asserted-by":"crossref","first-page":"e50342","DOI":"10.1371\/journal.pone.0050342","article-title":"GDF5 regulates TGF\u00df-dependent angiogenesis in breast carcinoma MCF-7 cells: In vitro and in vivo control by anti-TGF\u00df peptides.","volume":"7","author":"Margheri","year":"2012","journal-title":"PLoS ONE"},{"key":"R58-20-20230208","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/089686080602600103","article-title":"Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure.","volume":"26","author":"L\u00f3pez-Cabrera","year":"2006","journal-title":"Perit Dial Int"},{"key":"R59-20-20230208","first-page":"979","article-title":"Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma.","volume":"134","author":"Ke","year":"1989","journal-title":"Am J Pathol"},{"key":"R60-20-20230208","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1128\/MCB.00036-13","article-title":"LOXL4 is induced by transforming growth factor \u03b21 through Smad and JunB\/Fra2 and contributes to vascular matrix remodeling.","volume":"33","author":"Busnadiego","year":"2013","journal-title":"Mol Cell Biol"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201501000-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:24:40Z","timestamp":1786130680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201501000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2013070799","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}